Search

You searched for "Tumours"

728 results found

Management of diabetic macular oedema in vitrectomised eyes

1 August 2016 | | EYE - Vitreo-Retinal
Diabetic macular oedema (DMO) is one of the leading causes of blindness; its prevalence is on the rise with progressive increase in numbers of people suffering from diabetes. The management of DMO has evolved significantly over the past few years....

See sweet to C-suite: Imran Rahman

4 February 2025 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma
See also - See sweet to C-suite: Peter Holland In this three-part conversation series, Co-editor David Lockington speaks with highly influential individuals about their journey to the top, with advice for the next generation of leaders. Part Two: David speaks...
Strabismus journal cover image.

Changing surgery trends from 2009–2020

3 October 2024 | | EYE - Paediatrics, EYE - Strabismus
This paper reports a review of the number and type of surgeries over one decade in a Portuguese hospital. This was a retrospective review of 2050 surgeries. About 70% were strabismus surgery and the remainder included anterior segment and retinopathy...

A brief history of colour vision

1 April 2019 | | EYE - General
Andrew Want takes a look at how colour vision has evolved in humans and animals and how it differs across species. Colour vision is something that we often take for granted, but it has become so intrinsic to the way...

Transferring imaging from primary to secondary care (part 2)

5 October 2020 | | EYE - General
Transferring clinical imaging from high street optometrists to secondary care is an increasingly requested option, especially in the context of the COVID-19 pandemic. A wide variety of solutions exist to allow this, each with their own merits and shortcomings. In...

Emergency eye care in the UK: the way forward?

1 April 2018 | | EYE - Cornea, EYE - General
In this paper the authors highlight issues pertaining to the growing number of patients presenting to the emergency eye services in the UK. Data collection involved literature review, telephone surveys and email correspondence (n=142). Ninety-one lead clinicians responded and a...

My Top Five: Debunking common myths in ophthalmology and vision care

29 August 2024 | | EYE - General
In the field of eye health, numerous misconceptions persist. Let’s examine five prevalent myths and uncover the truth behind them. Myth 1: Wearing glasses weakens your eyesight Origin: This myth likely originated from the observation that people often need stronger...

Principles of management

1 August 2016 | | EYE - Cataract, EYE - Cornea, EYE - Pathology
Whatever section of pathology is to blame and wherever it strikes, the aim of treatment is always the same. Find the cause if you can. Establish the effects of the cause. Halt the pathological process if you can. Reverse its...

Ciliary body granuloma masquerading as a melanoma

3 February 2023 | | EYE - General
Introduction Sarcoidosis is a multisystem granulomatous inflammatory condition which predominantly affects the pulmonary system and intrathoracic lymph nodes, followed by ocular involvement [1]. We present an interesting patient who developed acute anterior uveitis and subsequent ciliary body granuloma clinically mimicking...

Understanding amniotic membrane grafts

1 June 2019 | | EYE - Cornea, EYE - General
Safa Elhassan gives a brief review of amniotic membrane grafts and their application in theatre and clinic-based settings. Amniotic membrane (AM) transplant has been an established adjuvant treatment for many corneal, conjunctival and scleral disorders in ophthalmic clinical practice with...

An update on inherited retinal disorders (part 2): Approaches to therapy for IRDs

1 December 2016 | | EYE - Vitreo-Retinal
Part 1 of this topic can be found here There are currently no proven cures for inherited retinal disease (IRD). However, multiple avenues of research are being investigated to better understand disease mechanisms and trial potential therapies that may slow...

Neovascular AMD: fresh recommendations underline standards of best practice

1 December 2013 |
The management of neovascular age-related macular degeneration (nAMD) has advanced dramatically over the past seven years, with the introduction of targeted new therapies that successfully maintain or improve vision in a majority of affected individuals. It’s a fast moving field,...